Saturday, March 28

UCLA given low rating for accessibility, transparency of biomedical research

UCLA performed poorly in 2020 for the equitability of its biomedical research, a nationwide student-led organization found. The Universities Allied for Essential Medicines, an organization devoted to the accessibility of medication, gave UCLA a D- overall score. Read more...

Photo: According to the recent Universities Allied for Essential Medicines report card, UCLA performed poorly in 2020 for the equitability of their biomedical research (Courtesy of Giselle Melendez/UCLA UAEM).


State bill could increase access to contraceptives through UC health plan

A proposed California bill could expand health care coverage to include contraceptives for students and employees enrolled in University of California health plans. Senate Bill 523 would require state employee and university health plans to include coverage of over-the-counter birth control and contraceptives. Read more...

Photo: If passed, Senate Bill 523 would expand contraceptive coverage for those using or enrolled in University of California health care plans and would prevent religious employers from retaliating against their employees who get contraceptive coverage outside of their employer provided health plan. (Kanishka Mehra/Photo editor)


UCLA conference highlights role of artificial intelligence in US-China relations

Artificial intelligence expert Kai-Fu Lee emphasized the importance of an international exchange of ideas in AI technology at a presentation Monday as part of a weeklong virtual UCLA conference. Read more...

Photo: Kai-Fu Lee, an expert in the artificial intelligence field, spoke about the need for an international exchange of ideas in AI technology at a virtual UCLA conference. (Madelynn Mackenzie/Daily Bruin)


UCLA-led pancreatic cancer research projects receive $6 million in grant funding

UCLA researchers were awarded two grants totaling $6 million to further pancreatic cancer therapy research. The National Institutes of Health gave the grants to two research projects at UCLA that investigate the possible side effects and efficacy of promising pancreatic cancer drugs in February. Read more...

Photo: UCLA researchers were awarded $6 million in grants for pancreatic cancer therapy research. (Kanishka Mehra/Photo editor)


California pauses Johnson & Johnson vaccine usage following federal recommendation

This post was updated April 13 at 3:28 p.m. California and Los Angeles County have paused the distribution of the Johnson & Johnson COVID-19 vaccine in accordance with a recommendation from federal health agencies following rare reports of people having severe blood clots after receiving the vaccine. Read more...

Photo: California will temporarily pause all distribution of the Johnson & Johnson single-dose COVID-19 vaccine, following a recommendation from the Centers for Disease Control and Prevention and the Food and Drug Administration. (Noah Danesh/Daily Bruin)



UCLA researchers examine effect of COVID-19 vaccine among health care workers

UCLA researchers are leading a Centers for Disease Control and Prevention-funded study to investigate the effectiveness of COVID-19 vaccinations among health care workers. The CDC allocated more than $11 million to four programs conducting studies evaluating the effectiveness of COVID-19 vaccines, including Preventing Emerging Infections Through Vaccine Effectiveness Testing, a study led by researchers from the David Geffen School of Medicine. Read more...

Photo: UCLA researchers are leading a Centers for Disease Control and Prevention-funded study to evaluate the effectiveness of the COVID-19 vaccines in health care. (Noah Danesh/Daily Bruin)



1 89 90 91 92 93 341